| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |